Dudediligence.

Aquestive Therapeutics, Inc

AQSTNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$1,858,211

11 notices · 338,226 sh

Oct 2025 to Oct 2026

Reported ·

$2,600,555

13 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

6 of 13 reported sales carry the 10b5-1 box. Together they are 0.44% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-09-15: Daniel Barber, Form 1442026-09-09: Sherry M. Korczynski, Form 1442026-08-17: Daniel Barber, Form 1442026-07-15: Daniel Barber, Form 1442026-06-23: JULIE KROP, Form 1442026-06-15: Daniel Barber, Form 1442026-05-15: Daniel Barber, Form 1442025-11-17: Carl N. Kraus, Form 1442025-10-15: Carl N. Kraus, Form 1442025-10-15: CASSIE JUNG, Form 1442025-10-15: Peter Boyd, Form 1442025-10-15: Boyd Peter E., sold2025-10-15: Kraus Carl N, sold2025-10-15: Jung Cassie, sold2026-03-10: Jung Cassie, sold2026-03-10: Korczynski Sherry, sold2026-03-10: TOTH A ERNEST JR, sold2026-03-10: Cioffi Melina, sold2026-03-10: BRAENDER LORI J, sold2026-03-10: Barber Daniel, sold2026-03-10: Boyd Peter E., sold2026-05-15: Barber Daniel, sold2026-06-15: Barber Daniel, sold2026-06-23: Krop Julie, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-09-15Daniel Barber, President and CEO$244,000
50,000 shplan 2025-09-15Form 4s on file end Jun 23144 ↗
2026-09-09Sherry M. Korczynski, Chief Commercial Officer$45,588
8,750 shplan 2026-06-10Form 4s on file end Jun 23144 ↗
2026-08-17Daniel Barber, President and CEO$106,250
25,000 shplan 2025-09-15Form 4s on file end Jun 23144 ↗
2026-07-15Daniel Barber, President and CEO$101,000
25,000 shplan 2025-09-15Form 4s on file end Jun 23144 ↗
2026-06-23JULIE KROP, Director$118,000
25,000 shplan 2025-09-15144 ↗
Form 4, 2026-06-24: sold 25,000 at $5.02 Form 4 ↗
2026-06-15Daniel Barber, President and CEO$104,250
25,000 shplan 2025-09-15144 ↗
Form 4, 2026-06-16: sold 25,000 at $4.16 Form 4 ↗
2026-05-15Daniel Barber, President and CEO$39,056
8,257 shplan 2025-09-15144 ↗
Form 4, 2026-05-18: sold 8,257 at $4.29 Form 4 ↗
2025-11-17Carl N. Kraus, Chief Medical Officer$286,209
53,100 shno plan dateno Form 4 on file144 ↗
2025-10-15Carl N. Kraus, Chief Medical Officer$278,943
40,544 sh10b5-1 plan144 ↗
Form 4, 2025-10-17: sold 20,272 at $7.00 Form 4 ↗
2025-10-15CASSIE JUNG, Chief Operating Officer$464,916
67,575 shplan 2024-12-10144 ↗
Form 4, 2025-10-17: sold 67,575 at $7.01 Form 4 ↗
2025-10-15Peter Boyd, Chief People Officer$70,000
10,000 shplan 2024-09-11144 ↗
Form 4, 2025-10-17: sold 10,000 at $7.00 Form 4 ↗